Alcon Commences Phase 2 Clinical Trial of NovaBay’s NVC-422 for Viral Conjunctivitis

LogoLogo

Back to: News Release

Download Formats

Share This Logo

URL:

Smart Multimedia Gallery

Graphic

Download Formats

More
http://www.businesswire.com/multimedia/google/20090705005009/en/1821156/Alcon-Commences-Phase-2-Clinical-Trial-NovaBay%E2%80%99s
http://www.businesswire.com/multimedia/google/20090705005009/en/1821156/Alcon-Commences-Phase-2-Clinical-Trial-NovaBay%E2%80%99sLogo

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.